Cover Image

Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab

Not available

Saved in:

Bibliographic Details
Main Author:	J. Finsterer (Author)
Format:	Book
Published:	PAGEPress Publications, 2022-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Reply to: "Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab" by Josef Finsterer
by: B. Maranini, et al.
Published: (2022)

Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis
by: B. Maranini, et al.
Published: (2021)

EXPERIENCE OF TREATMENT OF JUVENILE ANKYLOSING SPONDYLITIS WITH EYES LESION WITH ADALIMUMAB
by: E.I. Alexeeva, et al.
Published: (2009)

EXPERIENCE OF ADALIMUMAB TREATMENT IN PATIENT WITH JUVENILE ANKYLOSING SPONDYLITIS AND UVEITIS
by: E. V. Mitenko, et al.
Published: (2012)

EXPERIENCE OF TREATMENT OF JUVENILE ANKYLOSING SPONDYLITIS WITH EYES LESION WITH ADALIMUMAB
by: E.I. Alexeeva, et al.
Published: (2009)

Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab
by: M. Fernandes, et al.
Published: (2011)

Early Adalimumab and Anti‐Adalimumab Antibody Levels for Prediction of Primary Nonresponse in Ankylosing Spondylitis Patients
by: Xiaoliang Ding, et al.
Published: (2020)

Reactive Arthritis Triggered by Adalimumab and Leflunomide in a Patient with Ankylosing Spondylitis
by: Liu Y, et al.
Published: (2022)

SARS-CoV-2 messenger RNA vaccination during herpes zoster infection in an elderly man
by: Sho Katayama, MD, et al.
Published: (2022)

Herpes zoster reactivation after mRNA-1273 (Moderna) SARS-CoV-2 vaccination
by: Leelakrishna Channa, BS, et al.
Published: (2021)

Lobular capillary hemangioma in a patient with ankylosing spondylitis using adalimumab: an exuberant presentation,
by: Thadeu Santos Silva, et al.
Published: (2020)

SARS-CoV-2 mRNA vaccination and subsequent herpes zoster: Possible immune reconstitution by mRNA vaccination
by: Mitsuhito Ota, MD, PhD
Published: (2022)

Acute toxoplasmosis infection in a patient with ankylosing spondylitis treated with adalimumab: a case report
by: M. de Almeida Santos Jr, et al.
Published: (2011)

Physiotherapy in ankylosing spondylitis
by: Kamila Balcerska, et al.
Published: (2018)

Physiotherapy in ankylosing spondylitis
by: Kamila Balcerska, et al.
Published: (2018)

Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China
by: Liudan Tu, et al.
Published: (2020)

SARS-CoV-2 vaccinations complicated by transverse myelitis
by: Josef Finsterer
Published: (2022)

Evolution of Juvenile Ankylosing Spondylitis
by: Ye.V. Prohorov, et al.
Published: (2012)

Evolution of Juvenile Ankylosing Spondylitis
by: Ye.V. Prohorov, et al.
Published: (2013)

An improvement of the safety profile of SARS‐CoV‐2 vaccines is desirable
by: Josef Finsterer
Published: (2024)

Changes in Efficacy Indicators for Adalimumab Biosimilar Candidate (HS016) for the Treatment of Active Ankylosing Spondylitis at Various Time Points
by: Jinmei Su, et al.
Published: (2020)

Phase III, multi-centre, randomised, double blind, Placebo-controlled study for treatment of juvenile ankylosing spondylitis (AS) with Adalimumab
by: Thon A, et al.
Published: (2011)

Successful treatment of IgA nephropathy complicated by ankylosing spondylitis with recurrent anterior uveitis with adalimumab: one case report
by: Jia-biao Wu, et al.
Published: (2024)

Herpes zoster vaccination. An update
by: Khairuddin Djawad, et al.
Published: (2022)

Osteophytes in the Joints of Patients with Ankylosing Spondylitis: Manifestation of Osteoarthritis or Underlying Disease?
by: K. D. Dorogoykina, et al.
Published: (2020)

Clinical and Molecular Advances in Ankylosing Spondylitis
Published: (2012)

Surgical orodental implications in ankylosing spondylitis
by: Mohammad Mehdizadeh, et al.
Published: (2012)

Clinical study of patient with Ankylosing Spondylitis
by: Lee Jae-Min, et al.
Published: (2006)

Secukinumab for ankylosing spondylitis and psoriatic arthritis
by: Lubrano E, et al.
Published: (2016)

From rehabilitation to remission in ankylosing spondylitis
by: A. Spadaro, et al.
Published: (2011)

Ankylosing spondylitis: a multidisciplinary approach
by: Medhat El Shafei
Published: (2012)

Osteoporosis in Patients with Ankylosing Spondylitis - Review
by: Yasemin Dinçer Turan, et al.
Published: (2007)

Bone Mineral Density in Ankylosing Spondylitis
by: Bahar Çakmak, et al.
Published: (2003)

Sleep Quality in Patients with Ankylosing Spondylitis
by: Ece Çınar, et al.
Published: (2023)

Physiotherapy rehabilitation in patients with ankylosing spondylitis
by: Tiziana Nava
Published: (2019)

Fibroblast Insights into the Pathogenesis of Ankylosing Spondylitis
by: Liu Z, et al.
Published: (2023)

Ankylosing Spondylitis: From Cells to Genes
by: José Francisco Zambrano-Zaragoza, et al.
Published: (2013)

Effect of treatment with original or biosimilar adalimumab on SARS-CoV2 vaccination antibody titers
by: Eva Dokoupilová, et al.
Published: (2024)

Side effects of SARS-CoV-2 vaccines should be assessed by unbiased professionals on-site
by: Josef Finsterer
Published: (2022)

Validation of the Italian versions of the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Dougados Functional Index (DFI) in patients with ankylosing spondylitis
by: W. Grassi, et al.
Published: (2011)